Casein kinase 2 (CK2) increases survivin expression via enhanced β-catenin–T cell factor/lymphoid enhancer binding factor-dependent transcription
- 10 October 2006
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 103 (41), 15079-15084
- https://doi.org/10.1073/pnas.0606845103
Abstract
Increased expression of casein kinase 2 (CK2) is associated with hyperproliferation and suppression of apoptosis in cancer. Mutations in the tumor suppressor APC (adenomatous polyposis coli) are frequent in colon cancer and often augment beta-catenin-T cell factor (Tcf)/lymphoid enhancer binding factor (Lef)-dependent transcription of genes such as c-myc and cyclin-D1. CK2 has also been implicated recently in the regulation of beta-catenin stability. To identify mechanisms by which CK2 promotes survival, effects of the specific CK2 inhibitors 4,5,6,7-tetrabromobenzotriazole (TBB) and 2-dimethylamino-4,5,6,7-tetrabromo-1H-benzimidazole were assessed. TBB and 2-dimethylamino-4,5,6,7-tetrabromo-1H-benzimidazole significantly decreased proliferation and increased apoptosis of HT29(US) colon cancer cells. RT-PCR and immunoblot analysis revealed that both inhibitors decreased survivin mRNA and protein levels in HT29(US) cells. Similar effects were observed with TBB in human DLD-1 and SW-480 colorectal cells as well as ZR-75 breast cancer cells and HEK-293T embryonic kidney cells. Expression of GFP-CK2alpha in HEK-293T cells resulted in beta-catenin-Tcf/Lef-dependent up-regulation of survivin and increased resistance to anticancer drugs. Augmented beta-catenin-Tcf/Lef-dependent transcription and resistance to apoptosis observed upon GFP-CK2alpha expression were abolished by TBB. Alternatively, HEK-293T cells expressing GFP-survivin were resistant to TBB-induced apoptosis. Finally, siRNA-mediated down-regulation of CK2alpha in HEK-293T cells coincided with reduced beta-catenin and survivin levels. Taken together, these results suggest that CK2 kinase activity promotes survival by increasing survivin expression via beta-catenin-Tcf/Lef-mediated transcription. Hence, selective CK2 inhibition or down-regulation in tumors may provide an attractive opportunity for the development of novel cancer therapies.Keywords
This publication has 52 references indexed in Scilit:
- Caveolin-1 controls cell proliferation and cell death by suppressing expression of the inhibitor of apoptosis protein survivinJournal of Cell Science, 2006
- Naked DNA immunization as an approach to target the generic tumor antigen survivin induces humoral and cellular immune responses in miceImmunobiology, 2006
- THE WNT SIGNALING PATHWAY IN DEVELOPMENT AND DISEASEAnnual Review of Cell and Developmental Biology, 2004
- Survivin, versatile modulation of cell division and apoptosis in cancerOncogene, 2003
- CHOP Transcription Factor Phosphorylation by Casein Kinase 2 Inhibits Transcriptional ActivationJournal of Biological Chemistry, 2003
- CK2 Phosphorylation of the Armadillo Repeat Region of β-Catenin Potentiates Wnt SignalingPublished by Elsevier BV ,2003
- Role of the carboxyl terminus on the catalytic activity of protein kinase CK2α subunitFEBS Letters, 2002
- Destabilizing Influences in ApoptosisCell, 2002
- Selectivity of 4,5,6,7‐tetrabromobenzotriazole, an ATP site‐directed inhibitor of protein kinase CK2 (‘casein kinase‐2’)FEBS Letters, 2001
- Endogenous Protein Kinase CK2 Participates in Wnt Signaling in Mammary Epithelial CellsJournal of Biological Chemistry, 2000